Medication Interactions And Contraindications
Help Questions
NCLEX-PN › Medication Interactions And Contraindications
Which action should the nurse take to prevent a medication interaction?
Document that the client should avoid all dairy products for the duration of the antibiotic therapy.
Notify the PHCP that the calcium supplement is a direct contraindication for ciprofloxacin.
Instruct the client to take the calcium supplement at least 6 hours after the ciprofloxacin.
Administer both the antibiotic and the calcium supplement together with a full meal.
Explanation
Calcium and other divalent and trivalent cations (magnesium, aluminum, iron, zinc) bind with fluoroquinolone antibiotics like ciprofloxacin in the gastrointestinal tract to form insoluble chelation complexes. This significantly reduces the antibiotic's oral absorption and may result in inadequate blood levels, jeopardizing treatment of a severe infection. The solution is to separate administration: a minimum of 2 hours is recommended, with 6 hours being the more conservative and safer interval. The supplement need not be permanently discontinued (C) — it is a timing, not a true contraindication. Taking them together with food (A) does not prevent the chelation reaction; food does not interrupt cation binding to the antibiotic. Avoiding all dairy for the entire duration (B) is unnecessarily restrictive — dairy should simply not be consumed within the recommended separation window around the antibiotic dose.
Which information should the nurse reinforce with the client regarding this dietary habit?
"Grapefruit juice is encouraged because it helps the medication lower your cholesterol faster."
"It is safe to drink grapefruit juice as long as you take your medication in the evening."
"You should avoid grapefruit juice because it can increase the level of this medication in your blood."
"Grapefruit juice will cause the medication to be eliminated from your body too quickly."
Explanation
Grapefruit juice contains furanocoumarins that inhibit cytochrome P450 3A4 (CYP3A4) enzymes in the intestinal wall, which are responsible for the first-pass metabolism of simvastatin. When CYP3A4 is inhibited, more simvastatin is absorbed intact into the bloodstream, significantly increasing plasma drug levels. This raises the risk of dose-dependent toxicity, most critically statin-induced myopathy and potentially rhabdomyolysis. The client should be instructed to avoid grapefruit and grapefruit juice entirely while taking simvastatin. Grapefruit juice does not enhance cholesterol lowering (B). Choice C is incorrect and dangerously misleading: grapefruit juice inhibits CYP3A4 for 24 to 72 hours after consumption, so the timing of the dose relative to juice intake has no practical protective effect. The interaction involves decreased metabolism and increased drug levels, not accelerated elimination (D).
Which potential interaction should the nurse monitor for in this client?
Taking both medications together will cause the client's blood pressure to drop dangerously low.
The beta-blocker will cause the client to experience frequent episodes of hyperglycemia.
The beta-blocker may mask common symptoms of hypoglycemia, such as tachycardia.
The insulin will prevent the beta-blocker from effectively lowering the heart rate.
Explanation
Beta-blockers suppress the sympathetically mediated warning symptoms of hypoglycemia — most notably tachycardia, tremors, and palpitations — by blocking beta-1 adrenergic receptors. This means a client taking both insulin and a beta-blocker may experience a severe hypoglycemic episode without the usual autonomic warning signs that would prompt them to eat or seek help. Importantly, diaphoresis (sweating) is cholinergically mediated and is NOT masked by beta-blockers, so clients should be taught to monitor for sweating as their remaining warning sign. The beta-blocker does not itself cause hyperglycemia (A) — it may slightly impair glycogenolysis, but this is not the priority monitoring concern. Dangerous hypotension from this combination (C) is not a standard expected interaction. Insulin does not reduce the heart rate-lowering effect of beta-blockers (D).
The nurse recognizes that taking ibuprofen while also taking lisinopril and furosemide increases the risk for which complication?
Vitamin B12 deficiency resulting from poor medication absorption.
Severe hypoglycemic episodes related to the use of metformin.
Paradoxical hypertension and a sudden increase in heart rate.
Acute kidney injury and decreased effectiveness of the diuretic.
Explanation
The combination of an NSAID with an ACE inhibitor and a diuretic is a well-described pharmacological triple threat to renal function. NSAIDs reduce prostaglandin-mediated afferent arteriolar dilation, decreasing glomerular filtration. ACE inhibitors dilate the efferent arteriole, further reducing intraglomerular pressure. Diuretics reduce circulating volume, decreasing renal perfusion pressure. Together, these three mechanisms converge to dramatically reduce renal blood flow, precipitating acute kidney injury in a client who already has Stage 3 CKD. NSAIDs also cause sodium and water retention via prostaglandin inhibition, which directly antagonizes the therapeutic effects of both furosemide and lisinopril. Hypoglycemic episodes (B) are not a consequence of this drug combination. Paradoxical hypertension (C) partially reflects the BP-raising effect of NSAIDs, but the primary and most dangerous complication is acute kidney injury. Vitamin B12 deficiency (D) is unrelated to this drug combination.
Based on the client's recent use of ibuprofen, which nursing hypothesis should the nurse prioritize?
Risk for imbalanced nutrition related to long-term metformin use.
Risk for falls related to uncontrolled osteoarthritis pain.
Knowledge deficit regarding a low-sodium diet for chronic heart failure.
Risk for ineffective medication management related to the use of OTC drugs.
Explanation
The client has been self-medicating with an OTC NSAID that is contraindicated given her CKD, CHF, and current prescription medications — without awareness of the serious potential for harm. Risk for ineffective medication management related to OTC drug use is the priority nursing hypothesis because it directly addresses the active, potentially life-threatening safety issue presented by the ibuprofen. This hypothesis drives the most urgent nursing actions: stopping the ibuprofen, notifying the PHCP, and providing targeted education. Risk for imbalanced nutrition from metformin (A) is a long-term chronic concern, not acutely relevant to this admission. Risk for falls (B) addresses pain management indirectly but is not the most clinically urgent hypothesis given the renal and cardiovascular risks of current NSAID use. Low-sodium diet education (D) is appropriate for CHF management but is not the priority hypothesis triggered by the ibuprofen.
The nurse is preparing to administer the scheduled morning medications. The client asks, "Can I have one more ibuprofen before you give me those other pills?" What is the most appropriate response by the nurse?
"You should wait at least two hours after your other pills to take the ibuprofen."
"I need to check with your doctor first because ibuprofen can affect your kidney function."
"I will give you the ibuprofen now, but I must skip your blood pressure pill today."
"Yes, you can have it as long as you take it with a full glass of water."
Explanation
The nurse must withhold the ibuprofen and notify the PHCP before administering it, because it is contraindicated for this client given her CKD and the dangerous triple-whammy interaction with her current prescriptions. Choice B correctly reflects the nurse's responsibility: refuse the medication, provide a brief, honest explanation that respects the client without being alarming, and loop in the provider before any further action. Simply approving the ibuprofen with water (A) disregards the known contraindication. Suggesting a 2-hour wait (C) implies that timing can resolve a pharmacokinetic interaction that is not time-dependent in this way — the nephrotoxic risk from NSAIDs is cumulative and not mitigated by separating from other medications. Giving ibuprofen while skipping the blood pressure pill (D) is both clinically dangerous and outside the LPN/VN's scope of independent decision-making.
The nurse should recognize that taking aspirin with warfarin is a contraindication because it:
Causes the warfarin to be eliminated too quickly by the kidneys.
Increases the client's risk for significant bleeding.
Prevents the warfarin from effectively thinning the blood.
Leads to a high risk of developing a severe allergic reaction.
Explanation
Warfarin and aspirin affect the coagulation cascade through different but additive mechanisms. Warfarin inhibits the hepatic synthesis of vitamin K-dependent clotting factors (II, VII, IX, X), reducing the ability to form clots via the coagulation cascade. Aspirin irreversibly inhibits platelet cyclooxygenase, impairing platelet aggregation — the primary cellular mechanism of clot formation. Using both together produces an additive anticoagulant and antiplatelet effect that significantly elevates the risk of serious or life-threatening hemorrhage, including gastrointestinal bleeding and intracranial hemorrhage. The combination does not reduce warfarin's effectiveness (B) — on the contrary, the overall anticoagulation effect is increased. Warfarin is not eliminated by aspirin (C). An allergic reaction (D) is not an expected pharmacological interaction between these agents.
Which action should the nurse take next?
Administer both medications as prescribed by the PHCP.
Withhold both medications and notify the PHCP of the potential interaction.
Give the spironolactone but tell the client to skip the potassium supplement.
Advise the client to increase their intake of bananas and orange juice today.
Explanation
Spironolactone is a potassium-sparing diuretic that works by blocking aldosterone receptors, causing the kidney to retain potassium while excreting sodium and water. When combined with a potassium supplement, the additive potassium load creates a high risk for life-threatening hyperkalemia, which can cause fatal cardiac arrhythmias. The nurse must withhold both medications and notify the PHCP so an informed decision can be made about the regimen — the nurse should not independently determine which medication to give or omit. Administering both as prescribed (A) puts the client at immediate risk. Independently deciding to give spironolactone while withholding the supplement (C) bypasses the PHCP and makes an unilateral clinical judgment outside LPN/VN scope. Recommending additional dietary potassium sources (D) would further worsen the risk of hyperkalemia in this already dangerous combination.
The nurse should identify that this medication is a contraindication for this client because it can cause:
Excessive fluid retention and peripheral edema.
A significant increase in the client's blood glucose levels.
Severe hypertension and a rapid heart rate.
Bronchoconstriction and an acute asthma attack.
Explanation
Propranolol is a non-selective beta-blocker that blocks both beta-1 receptors (cardiac) and beta-2 receptors (smooth muscle, including bronchial smooth muscle). In clients with asthma, beta-2 receptor activation causes bronchodilation — blocking these receptors with propranolol removes this bronchodilatory tone and can trigger bronchoconstriction and acute bronchospasm, precipitating a potentially life-threatening asthma attack. The nurse must withhold this medication and notify the PHCP before administration. Cardioselective beta-1 blockers (such as metoprolol or atenolol) have less beta-2 activity and are generally preferred when a beta-blocker is required for a client with asthma, though they are not entirely risk-free. Propranolol causes bradycardia and hypotension (not hypertension or tachycardia as in A). While beta-blockers can modestly impair glucose recovery from hypoglycemia, hyperglycemia (C) is not the primary contraindication concern. Fluid retention (D) is not a characteristic adverse effect of beta-blockers.
The nurse should recognize that this electrolyte imbalance increases the client's risk for:
Significant fluid volume excess and edema.
Digoxin toxicity and cardiac arrhythmias.
Decreased therapeutic effect of the furosemide.
A severe allergic reaction to the digoxin.
Explanation
Furosemide is a loop diuretic that causes potassium wasting, and this client's potassium of 3.1 mEq/L reflects hypokalemia. This is a critical safety concern in a client receiving digoxin because potassium and digoxin compete for the same binding site on the Na-K-ATPase pump in cardiac cells. When potassium is low, digoxin has less competition for these receptor sites and binds more avidly, producing a toxic effect — causing dangerous cardiac arrhythmias — even when the digoxin serum level itself appears within a therapeutic range. The nurse must withhold the digoxin and notify the PHCP to address the hypokalemia before continuing the medication. Hypokalemia does not decrease furosemide's diuretic effect (B). An allergic reaction (C) is unrelated to electrolyte status. Hypokalemia causes fluid shifts but does not produce fluid volume excess (D).